Radiation therapy for oncological emergencies.

Abstract:

AIMS AND BACKGROUND:Radiation therapy holds a fundamental role in oncological emergencies such as superior vena cava syndrome, spinal cord compression and endocranial hypertension. The purpose of our study was, by comparing schedules of treatment, to confirm the efficacy of hypofractionated radiation therapy. METHODS:From January 1994 to December 1998, 43 patients with superior vena cava syndrome, 37 patients with metastatic spinal cord compression and 108 patients with endocranial hypertension secondary to metastasis were treated at our institution. In the group of patients with superior vena cava syndrome, radiotherapy schedules were: 4 Gy x 5 to a total dose of 20 Gy (23 patients) and 3 Gy x 10 to a total dose of 30 Gy (20 patients). In the group of patients with spinal cord compression, radiation schedules were: 3 Gy x 10 to a total dose of 30 Gy (15 patients); 4 Gy x 5 to a total dose of 20 Gy (12 patients); a single fraction of 8 Gy in 10 cases, repeated after 1 week in 7 responder cases to a total dose of 16 Gy. 5 out of 37 patients were underwent to laminectomy plus stabilization of the spine and post-operative radiotherapy. In the group of patients with endocranial hypertension, radiotherapy schedules were: 6 Gy x 2 to a total dose of 12 Gy (53 patients), repeated after 4 weeks in 34 responder patients and 3 Gy x 10 to a total dose of 30 Gy (55 patients). RESULTS:The patients with superior vena cava syndrome, revaluated after 4 weeks at the end of treatment, obtained a partial remission of symptomatology in 73.9% with 20 Gy and in 75% with 30 Gy. The patients with spinal cord compression obtained symptomatic relief in 73.3% with 30 Gy, in 66.6% with 20 Gy and in 70% of cases treated with 8 Gy. The patients with endocranial hypertension obtained symptomatic relief in 64.1% with 12 Gy and in 63.3% with 30 Gy. CONCLUSION:Histology, pretreatment and performance status were important prognostic factors for the response to therapy. Our results demonstrated no significant difference among different schedules of radiotherapy and confirmed the importance of radiotherapy for oncological emergencies: it improves the quality of life and, in responding patients, is associated with a longer survival time.

journal_name

Anticancer Res

journal_title

Anticancer research

authors

Donato V,Bonfili P,Bulzonetti N,Santarelli M,Osti MF,Tombolini V,Banelli E,Enrici RM

subject

Has Abstract

pub_date

2001-05-01 00:00:00

pages

2219-24

issue

3C

eissn

0250-7005

issn

1791-7530

journal_volume

21

pub_type

临床试验,杂志文章
  • Symptomatic Radiation Pneumonitis After Accelerated Partial Breast Irradiation Using Three-dimensional Conformal Radiotherapy.

    abstract:AIM:To examine the relationship between symptomatic radiation pneumonitis and lung dose-volume parameters for patients receiving accelerated partial breast irradiation (APBI) using three dimensional-conformal radiotherapy (3D-CRT). PATIENTS AND METHODS:The prescribed radiation dose was 30 Gy in 5 fractions over 10 day...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Shikama N,Kumazaki YU,Miyazawa K,Miyaura K,Kato S,Nakamura N,Kawamori J,Shimizuguchi T,Saito N,Saeki T

    更新日期:2016-05-01 00:00:00

  • Interstitial lung disease associated with docetaxel in patients with advanced non-small cell lung cancer.

    abstract:BACKGROUND:Docetaxel is a well tolerated chemotherapy for non-small cell lung cancer (NSCLC). However, few studies have investigated interstitial lung disease (ILD) associated with docetaxel. The purpose is to describe the incidence of this complication by using NSCLC patients. PATIENTS AND METHODS:Between September 2...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Tamiya A,Naito T,Miura S,Morii S,Tsuya A,Nakamura Y,Kaira K,Murakami H,Takahashi T,Yamamoto N,Endo M

    更新日期:2012-03-01 00:00:00

  • Phase II and III studies with new drugs for non-small cell lung cancer: a systematic review of the literature with a methodology quality assessment.

    abstract::We carried out a systematic review of new drugs active in non-small cell lung carcinoma (NSCLC). Fifty five phase II and III trials were reviewed (vinorelbine (19 trials), paclitaxel (15), gemcitabine (11), docetaxel (6), topotecan (2) or irinotecan (2)). The first four ones could be considered as active drugs when gi...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Meert AP,Berghmans T,Branle F,Lemaître F,Mascaux C,Rubesova E,Vermylen P,Paesmans M,Sculier JP

    更新日期:1999-09-01 00:00:00

  • Methodological aspects of the 6-day subrenal capsule assay for measuring the response of human tumors to anticancer agents.

    abstract::Methodological aspects of testing chemosensitivity by the 6-day subrenal capsule (SRC) assay in immunocompetent mice were investigated. Human tumor xenografts, serially transplanted in athymic nude mice, were used as source of material. All drugs were given by the intravenous route. Administration of the drugs on days...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Aamdal S,Fodstad O,Pihl A

    更新日期:1985-07-01 00:00:00

  • Construction and transfection of a ribozyme targeting human caspase-3.

    abstract::Caspase-3 is a key executioner cysteine protease involved in programmed cell death or apoptosis. A ribozyme to human caspase-3 was designed, tested by in vitro cleavage, and transfected into a drug-resistant variant (DLKP-A5F) of a human lung carcinoma cell line (DLKP). By both stable and transient transfection, this ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Cronin D,Daly C,O'Doherty T,Heenan M,Scanlon KJ,Clynes M

    更新日期:2004-03-01 00:00:00

  • Vascular endothelial growth factor expression is an independent negative predictor in extrahepatic biliary tract carcinomas.

    abstract:BACKGROUND:Vascular endothelial growth factor (VEGF) is one of the most important factors for angiogenesis in various tumors. However, its clinical significance in extrahepatic biliary tract carcinoma remains unclear. MATERIALS AND METHODS:To clarify the association of VEGF expression with the clinicopathological feat...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Hida Y,Morita T,Fujita M,Miyasaka Y,Horita S,Fujioka Y,Nagashima K,Katoh H

    更新日期:1999-05-01 00:00:00

  • Effect of the progestagen Promegestone (R-5020) on mRNA of the oestrone sulphatase in the MCF-7 human mammary cancer cells.

    abstract::Using reverse transcriptase polymerase chain reaction amplification it was possible to detect the presence of oestrogen sulphatase mRNA in different hormone-dependent (MCF-7, T-47D) and hormone-independent (MDA-MB-231, MDA-MB-468) mammary cancer cell lines. The expression of this mRNA is significantly higher in T-47D ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Pasqualini JR,Maloche C,Maroni M,Chetrite G

    更新日期:1994-07-01 00:00:00

  • Successful treatment with three-weekly paclitaxel of an anthracycline-refractory classical Kaposi's sarcoma.

    abstract::Paclitaxel has been approved as second-line therapy after anthracyclines in AIDS-Kaposi's sarcoma (KS) patients. To date, only one patient with classical KS and treated with standard dose (175 mg/m2) 3-weekly paclitaxel as first line therapy has been reported in the literature. Herein, the first case is presented of a...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Silvestris N,Galetta D,Colucci G

    更新日期:2009-02-01 00:00:00

  • Process development for the practical production of eldecalcitol by linear, convergent and biomimetic syntheses.

    abstract::Eldecalcitol [1α,25-dihydroxy-2β-(3-hydroxypropoxy)vitamin D(3)], an analog of calcitriol (1α,25-dihydroxyvitamin D(3)), possesses a hydroxypropoxy substituent at the 2β-position of calcitriol. Eldecalcitol has potent biological effects on bone disease such as osteoporosis. The marketing of eldecalcitol has very recen...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kubodera N,Hatakeyama S

    更新日期:2012-01-01 00:00:00

  • Activity of tamoxifen and new antiestrogens on estrogen receptor positive and negative breast cancer cells.

    abstract::The effect of some new antiestrogens (ICI 164384, ICI 182780, Ly 133314 and Ly 117018) on the growth of a panel of breast cancer cell lines (MDA-MB 231, BT20, MCF7 and T47D) was studied. Their antiestrogenic activity was investigated in the presence of a physiologic concentration of estradiol and compared with the eff...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Coradini D,Biffi A,Cappelletti V,Di Fronzo G

    更新日期:1994-05-01 00:00:00

  • Identification, Molecular Characterization and Alternative Splicing of Three Novel Members of the Canine Kallikrein (Klk)-related Peptidase Family.

    abstract:BACKGROUND/AIM:Kallikrein-related peptidases (KLKs) comprise a serine protease family with prominent roles in tissue physiology and disease pathogenesis, including cancer. Previously, we have characterized canine Klk4-10 and -14. Herein, we continue our efforts by characterizing three novel members of the canine family...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Angelopoulou K,Karagiannis GS

    更新日期:2015-05-01 00:00:00

  • The Effect of Payer Status on Survival of Patients with Stage I/II Non-small Cell Lung Cancer: NCDB 1998-2011.

    abstract:BACKGROUND:One of the challenges to improving access to care is identifying disparities in health care. To determine the influence of insurance status on outcome for patients with non-small cell lung cancer (NSCLC), we analyzed data from the National Cancer Data Base (NCDB) from 1998-2011. MATERIALS AND METHODS:Data f...

    journal_title:Anticancer research

    pub_type: 历史文章,杂志文章

    doi:

    authors: Shi R,Diaz R,Shi Z,Duvall E,Mills G

    更新日期:2016-01-01 00:00:00

  • Synergistic Effects of a Smac Mimetic with Doxorubicin Against Human Osteosarcoma.

    abstract:BACKGROUND/AIM:Second mitochondria-derived activator of caspase (Smac) is a proapoptogenic mitochondrial protein that antagonizes inhibitors of apoptosis proteins (IAPs), resulting in induction of apoptosis. In the present study we investigated the effects of a Smac mimetic in combination with doxorubicin against osteo...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.12058

    authors: Kamata E,Kawamoto T,Ueha T,Hara H,Fukase N,Minoda M,Morishita M,Takemori T,Fujiwara S,Nishida K,Kuroda R,Kurosaka M,Akisue T

    更新日期:2017-11-01 00:00:00

  • 12-O-retinoylphorbol-13-acetate (RPA) behaves like a retinoid-derivative in binding to retinol-binding-protein: a correlation with its specific action as an incomplete tumor promoter?

    abstract::12-O-retinoylphorbol-13-acetate (RPA), an incomplete tumor promoter of the phorbol ester type and protein kinase C (PKC) activator, consists of two characteristic structural elements: the phorbol body and the retinoyl ester chain. Therefore, possible binding of the incomplete tumor promoter RPA to the human transport ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Schlatterer K,Gminski R,Schlatterer J,Hecker E,Chandra P,Schlatterer B,Krauter G,Chandra A

    更新日期:2005-09-01 00:00:00

  • Intrapelvic fat makes robot-assisted radical prostatectomy difficult.

    abstract:AIM:We investigated the relationship between a new index considering the estimated working space and difficulty of robot-assisted radical prostatectomy (RARP) using our database. PATIENTS AND METHODS:Working height was calculated by the obstetric conjugate diameter minus the bladder and rectal wall thicknesses minus t...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kadono Y,Ueno S,Makino T,Ofude M,Izumi K,Gabata T,Namiki M

    更新日期:2014-10-01 00:00:00

  • Cryosurgery plus adjuvant systemic alpha2-interferon for HPV-associated lesions.

    abstract:OBJECTIVE:The authors report their experience in patients with adjuvant systemic 2-interferon with the aim of defining the effectiveness, side-effects, indications and limitations of this treatment. MATERIALS AND METHODS:From January 1989 to December 1996, 123 patients with genital, anorectal and perineal HPV lesions ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Scala M,Bonelli G,Gipponi M,Margarino G,Muzza A

    更新日期:2002-03-01 00:00:00

  • p53 gene mutants expression, cellular proliferation and differentiation in oesophageal carcinoma and non-cancerous epithelium.

    abstract::An immunohistochemical study of 155 squamous cell carcinomas of the oesophagus, squamous epithelium adjacent to the tumour (n = 80), dysplastic epithelium (n = 16) and controls (n = 23) indicates that Ki67 and p53 expression is frequently present in premalignant oesophageal lesions and their related squamous cell carc...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Jaskiewicz K,De Groot KM

    更新日期:1994-01-01 00:00:00

  • rIL-2 in metastatic soft tissue sarcomas refractory to chemotherapy: response and enhancement of further chemosensitivity.

    abstract::Chemotherapy (CT) in advanced and metastatic soft tissue sarcoma (STS) has a reported response rate of 17 to 30%, with a median survival of 30 months. Experimental and clinical studies have demonstrated some response with high-dose intravenous recombinant Interleukin-2 (r-IL2). We report a retrospective analysis of tw...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Gravis G,Viens P,Delva R,Baume D,Blaise D,Ternier F,Houvenaeghel G,Brandely M,Resbeut M,Maraninchi D

    更新日期:1998-09-01 00:00:00

  • Initial experience with hepatic intraarterial fotemustine and interferon alpha 2b combination for treatment of liver tumors.

    abstract:BACKGROUND:Locoregional treatments represent a good option for patients suffering from hepatocellular carcinoma (HCC) not eligible for resection or transplantation. Locoregional approaches include a wide spectrum of therapeutic methods and hepatic intra-arterial drug infusion is also considered. Fotemustine is a chemot...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Vitale FV,Romeo P,DI Maggio EM,Parisi A,Malaponte E,Calì S,Vasta F,Panebianco V,Arcoria D,Ferraù F

    更新日期:2011-12-01 00:00:00

  • Induction chemotherapy in non small cell lung cancer stage IIIa-b and IV and second-line treatment.

    abstract::This study investigates the treatment management and survival of inoperable advanced non-small cell lung cancer (NSCLC) patients. The objective was to treat all patients with induction chemotherapy and then to stratify them for surgery, radiotherapy, second-line chemotherapy or supportive treatment. Of the 359 patient...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Stathopoulos GP,Dafni UG,Malamos NA,Rigatos S,Kouvatseas G,Moschopoulos N

    更新日期:1999-07-01 00:00:00

  • Thrombocytosis Portends Adverse Prognosis in Colorectal Cancer: A Meta-Analysis of 5,619 Patients in 16 Individual Studies.

    abstract:AIM:The current study aimed to determine the prognostic significance of thrombocytosis in patients with colorectal cancer (CRC) by a meta-analysis of the literature. PATIENTS AND METHODS:The meta-analysis followed the 2009 guidelines of Preferred Reporting Items for Systematic Reviews and Meta-Analyses. A systematic l...

    journal_title:Anticancer research

    pub_type: 杂志文章,meta分析,评审

    doi:10.21873/anticanres.11878

    authors: Gu D,Szallasi A

    更新日期:2017-09-01 00:00:00

  • The antitumour effect of {gamma}{delta} T-cells is enhanced by valproic acid-induced up-regulation of NKG2D ligands.

    abstract:UNLABELLED:The aim of this study wsa to evaluate the additive effect of valproic acid (VPA) to γδ T-cell cytotoxicity against bladder cancer cells. MATERIALS AND METHODS:Human bladder cancer cell lines TCCSUP and 253J were treated with VPA and mRNA expression of natural killer group 2D (NKG2D) ligands was determined. ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Suzuki T,Terao S,Acharya B,Naoe M,Yamamoto S,Okamura H,Gotoh A

    更新日期:2010-11-01 00:00:00

  • Clinical value of bisphosphonates in cancer therapy.

    abstract::The therapeutic opportunities for an improved management of malignant bone disease are currently extensively studied. The conventional management of symptomatic bone lesions in patients with advanced cancer involves various combinations of local and systemic standard anticancer therapies and the symptomatic treatment ...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Lüftner D,Henschke P,Possinger K

    更新日期:2007-07-01 00:00:00

  • A Scoring System to Predict the Development of Bone Metastasis After Radical Resection of Colorectal Cancer.

    abstract:BACKGROUND/AIM:To develop a scoring system to predict bone metastasis after radical resection within 5 years. PATIENTS AND METHODS:We evaluated the patient records of 1,749 patients, of whom 50 patients developed bone metastasis. Treatment-related factors (age, gender, localization, histology, preoperative carbohydrat...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.11938

    authors: Li A,Käsmann L,Rades D,Fu C

    更新日期:2017-09-01 00:00:00

  • Screening for antimitotic compounds using the cdc25 tyrosine phosphatase, an activator of the mitosis-inducing p34cdc2/cyclin Bcdc13 protein kinase.

    abstract::A universal intracellular factor, the "M phase-promoting factor" (MPF), triggers the G2/M transition of the cell cycle in all organisms. In late G2, it is present as an inactive complex of tyrosine-phosphorylated p34cdc2 and unphosphorylated cyclin Bcdc13. In M phase, its activation as an active MPF displaying histone...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Baratte B,Meijer L,Galaktionov K,Beach D

    更新日期:1992-05-01 00:00:00

  • Cytokine stimulation of antibody-dependent cellular cytotoxicity (ADCC) enhances cytolytic but not binding capacity of peritoneal macrophages.

    abstract::Macrophages in varying states of activation differ in their ability to perform antibody-dependent cellular cytotoxicity (ADCC). To define further the activation requirements for macrophages to perform cytolytic functions, we stimulated peptone-elicited peritoneal macrophages, which exhibit only a low level of ADCC, wi...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Fehr HG,Fan S,Lötzerich H,Appell HJ

    更新日期:1990-05-01 00:00:00

  • Exposure to sorbitol induces resistance to cisplatin in human non-small-cell lung cancer cell lines.

    abstract::Cisplatin is the most active anticancer agent for lung cancer. It has been reported that intracellular accumulation of cisplatin is important in determining resistance to cisplatin, which may be modulated by Na+, K(+)-ATPase activity. On the other hand, it is well-known that sorbitol, a metabolite of glucose mediated ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Bando T,Fujimura M,Kasahara K,Shibata K,Shirasaki H,Heki U,Iwasa K,Ueda A,Tomikawa S,Matsuda T

    更新日期:1997-09-01 00:00:00

  • The A.H.E.A.D. method: a quantitative automated measurement of the hematotoxicity of anticancer drugs.

    abstract::Among the limiting side-effects of anticancer drugs, hematological toxicity is the most frequent. Hematological analysis focuses on nucleated blood cells from mouse peripheral blood or hematopoietic organs (bone marrow, spleen, thymus). We have developed an automated method called A.H.E.A.D. (Automated Hematotoxicolog...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Saint-Dizier D,Sancier M,Cudennec CA

    更新日期:1990-05-01 00:00:00

  • Clinical implications of the ISC technique for breast cancer radiotherapy and comparison with clinical recommendations.

    abstract:PURPOSE:The present project studied the implications of using the irregular surface compensator (ISC) technique in comparison to three-dimensional conformal radiation therapy (3D-CRT) for breast cancer treatment. ISC is an electronic compensation algorithm that modulates the fluence across the radiation fields to compe...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Flejmer AM,Josefsson D,Nilsson M,Stenmarker M,Dasu A

    更新日期:2014-07-01 00:00:00

  • Development and prevention of metastasis.

    abstract::Metastatic spread of malignancy is the primary cause of treatment failure and subsequent death in cancer patients. All cancers have the capability to metastasize, however, there are notable exceptions which rarely if ever metastasize. These include basal cell carcinoma, or cancers which are primarily locally invasive ...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Kohn EC

    更新日期:1993-11-01 00:00:00